Clinical Trial Update: Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Basal Ganglia Intracerebral Hemorrhage at the Early Stage [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluates neuroendoscopic hematoma evacuation combined with methylprednisolone sodium succinate for early treatment of basal ganglia in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage
• Stroke

Drugs mentioned

• SOLU-MEDROL (Methylprednisolone sodium succinate)

Snippet

Sponsor: Yong Jiang | Conditions: Stroke, Intracerebral Hemorrhage Basal Ganglia | Phase 4 | Status: NOT_YET_RECRUITING